Development and Validation of a New Staging System for Esophageal Squamous Cell Carcinoma Patients Based on Combined Pathological TNM, Radiomics, and Proteomics.
Shao-Jun ZhengChun-Peng ZhengTian-Tian ZhaiXiu-E XuYa-Qi ZhengZhi-Mao LiEn-Min LiWei LiuLi-Yan XuPublished in: Annals of surgical oncology (2022)
The ProtRadpTNM2c staging system, based on combined pTNM stage, radiomic, and proteomic features, improves the predictive performance of the classical pTNM staging system.